Grasiele V. Tavares
Belo Horizonte, MG 30130100, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Immunotherapeutics Combining a Recombinant Chimeric Protein, Monophosphoryl Lipid A, and Miltefosine Against Visceral Leishmaniasis.
Journal: Pathogens (Basel, Switzerland)
Published: September 22, 2025
Recombinant small myristoylated protein-3 and synthetic peptide as diagnostic and prognostic biomarkers for tegumentary leishmaniasis.
Journal: Parasitology international
Published: September 17, 2025
Urine- and serum-based ELISA using a new recombinant chimeric protein to diagnose tegumentary and visceral leishmaniasis: a preliminary study.
Journal: Experimental parasitology
Published: February 07, 2025
Preclinical evaluation of immunogenicity and protective efficacy of a recombinant chimeric protein vaccine against visceral leishmaniasis.
Journal: Parasitology
Published: November 28, 2024
Urine and serum-based ELISA using a recombinant protein and synthetic peptide for the diagnosis of tegumentary leishmaniasis.
Journal: Diagnostic microbiology and infectious disease
Published: October 23, 2024
Treatment using vanillin-derived synthetic molecules incorporated into polymeric micelles is effective against infection caused by Leishmania amazonensis species.
Journal: Experimental parasitology
Published: November 15, 2023
A recombinant chimeric antigen constructed with B-cell epitopes from Mycobacterium leprae hypothetical proteins is effective for the diagnosis of leprosy.
Journal: Diagnostic microbiology and infectious disease
Published: November 08, 2023
Last Updated: 09/26/2026